Advances in Surgical Procedures Driving the Global Breast Implants Market 

Global breast implants market to exhibit a strong growth over the next couple of years asserts Market Research Future (MRFR). Breast implants market size is expected to reach USD 3.7 billion by 2030 at 6.4% CAGR during the forecast period 2022-2030. Breast implants witness widespread popularity among the women population, especially in advanced countries. The product has undergone several phases of evolution over the years. Modern breast implants are made of silica solutions, saline or silicone gel. These implants are used to reconstruct, repair and enhance the breast implants market. According to data released by the American Society of Plastic Surgeons, in 2015, nearly 106,000 breast reconstruction procedures were undertaken in the U.S.

More and more individuals are willing to spend on improving self-appearance, this is a major market driver. Advances in technology have made these procedures safer and more effective. At the same time, the increased number of skilled plastic surgeons is partly influencing the market growth. Plastic surgery is a high-growth segment in the global healthcare market, which is prompting investment towards medical tourism that covers cosmetic services. However, penetration remains low in price-sensitive markets, as such procedures are expensive and entails post-surgery maintenance. 

Segmental Overview 

The segmental analysis of the global breast market has been conducted on the basis of shape, application, product, and end user. 

Based on shape, the market has been anatomical and round. Based on application, the market has been segmented into breast reconstruction and breast augmentation. Based on product, the market has been segmented into saline breast implants, round breast implants, gummy bear breast implants, silicone breast implants, textured breast implants, structured saline breast implants and smooth breast implants. Based on end-user, the market has been segmented into clinics, ambulatory surgical centers, hospitals, cosmetic centers and others. 

Request Free Sample Copy at: 

https://www.marketresearchfuture.com/sample_request/6325

Global Breast Implants Market: Regional Segmentation 

MRFR is its report that covers regions such as Europe, North America and South America, the Middle East Africa (MEA) and Asia-Pacific. North America is the largest market for breast implants. Demand for breast restructuring and enhancement procedures continues to grow in the region. Cosmetic surgeries make a significant contribution to the overall revenues for the cosmetics industry. The uptake in silicone breast implants in countries such the U.S. and Canada has been rapid. Europe is the second most attractive market for breast implants. A sizable patient pool for breast reconstruction is viewed as a major market driver. In addition, the presence of cutting-edge medical infrastructure and cosmetics solution providers put the region at a favorable position in the global breast implants market. In APAC, sustained growth is expected over the next couple of years. Rising disposable income, increased acceptance of silicon-based body enhancement products and rising consciousness regarding self-appearance are some of the factors supporting the market growth in the region. Breast enhancement procedures have increased significantly in countries such as China and India. The Middle East Africa (MEA) market has relatively smaller market share, however, has potential to grow sharply in the future. 

Competitive Landscape

Allergan (Actavis), GC Aesthetics, Establishment Labs S.A., GROUPE SEBBIN SAS, Laboratoires Arion, CEREPLAS, Ideal Implant Inc., Guangzhou Wanhe Plastic Materials Co. Ltd., Sientra Inc., Polytech Health Aesthetics GmbH, Shanghai Kangning Medical Supplies Ltd., Hans Biomed Co. Ltd., Mentor Worldwide LLC, and Shanghai Kangning Medical Device Co. Ltd. are among the leading companies operating in the global breast implants market. 

Industry News Updates 

Ireland based pharmaceutical company Allergan Plc is set to recall and halt the commercial distribution of its Biocell textured breast implants in Canada. This came after the country’s apex health agency ordered to cease the commercial distribution and marketing of the implants, citing potential health risks. 

A privately-held medical technology company GC Aesthetics, Inc., recently unveiled two new products. The products will leverage advanced software technologies to offer unique solutions to patients who want to enhance their physical appearance. 

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/breast-implants-market-6325

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com